House Democrats are divided on President Donald Trump’s executive order aimed at dramatically reducing U.S. drug prices. While some lawmakers express cautious optimism, others dismiss the move as symbolic with little real impact. The order, announced by Trump on Monday, directs the Department of Health and Human Services to set price targets for pharmaceutical companies, aiming to align U.S. drug prices with those in other developed countries. Trump claims the initiative will cut prescription drug and pharmaceutical prices by 50 to 90%, but many Democratic lawmakers remain skeptical, questioning the order’s effectiveness and whether it will result in meaningful price reductions for American patients.